Cannabinoid-induced antinociception is mediated by a spinal α2-noradrenergic mechanism

Brain Research

Volumn 559, Issue 2, 1991, Pages 309-314

  Lichtman, Aron H ^a   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; METHYSERGIDE; TETRAHYDROCANNABINOL; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; HYPOTHERMIA; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMAL; BODY TEMPERATURE; CANNABINOIDS; CATALEPSY; INJECTIONS, SPINAL; MALE; METHYSERGIDE; NOREPINEPHRINE; RATS; RATS, INBRED STRAINS; RECEPTORS, ADRENERGIC, ALPHA; SEROTONIN ANTAGONISTS; SPINAL CORD; SUPPORT, U.S. GOV'T, P.H.S.; YOHIMBINE;

EID: 0025934332     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(91)90017-P     Document Type: Article

References (41)

1. Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat
2. Bilateral intranigral microinjection of morphine and opioid peptides produces antinociception in rats
3. Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat
4. Antinociception induced by local injections of carbachol into the nucleus raphe magnus in rats: alteration by intrathecal injection of monoaminergic antagonists
5. A method for determining the loss of pain sensation
6. Determination and characterization of a cannabinoid receptor in rat brain
7. Cannabinoid Pharmacology
8. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone test
9. Electric stimulation of the substantia nigra does not increase tail-flick latency in the rat
10. Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract ofCannabis sativa L
11. Investigations on behavioral effects of an extract ofCannabis sativa L. in the rat
12. Characterization of inhibition of the spinal nociceptive tail-flick response in the rat from the medullary lateral reticular nucleus
13. 9-Tetrahydrocannabinol and extrapyramidal system
14. 9-THC in the rat
15. Afferent and efferent connections of the rat tail flick reflex (a model used to analyze pain control mechanisms)
16. Control systems for descending nociceptive afferent processing: the descending inhibitory pathways
17. Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or phentolamine
18. Some narcotic antagonists in the benzomorphan series
19. Cannabinoid receptor localization in brain
20. Nonclassical cannabinoid analgetics inhibit adenylate cyclase, development of a cannabinoid receptor model
21. A pharmacological analysis of levonantradol antinociception in mice
22. Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites
23. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice
24. The thermoregulatory effects of noradrenaline, serotonin and carbachol injected into the rat subarachnoid space
25. Structural requirements for cannabinoid-induced antinociceptive activity in mice
26. Cellular effects of cannabinoids
27. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
28. Decrease in morphine's analgesic action and increase in its cataleptic action by 6-hydroxydopamine injected bilaterally into caudate and putament areas; partial restoration byl-DOPA plus decarboxylase inhibition
29. The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice
30. Effects of cannabinoids on thermoregulation; a brief review
31. An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain
32. The Structure—activity relationship of cannabinoid discriminative stimulus and its interaction with catalepsy in rats
33. Structure—activity relationships in cannabinoids
34. Role of catecholamines in the hypothermic activity of cannabis in albino rats
35. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray
36. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat
37. Pharmacology of spinal adrenergic system which modulate spinal nociceptive processing
38. Chronic catheterization of the spinal subarachnoid space
39. Spinal serotonin terminal system mediates antinociception